Osang Healthcare Co.,Ltd (KOSDAQ:036220)
12,750
-140 (-1.09%)
Nov 20, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Revenue
Osang Healthcare Co.,Ltd had revenue of 42.03B KRW in the quarter ending June 30, 2025, with 110.19% growth. This brings the company's revenue in the last twelve months to 113.97B, up 51.31% year-over-year. In the year 2024, Osang Healthcare Co.,Ltd had annual revenue of 80.49B, down -77.38%.
Revenue (ttm)
113.97B
Revenue Growth
+51.31%
P/S Ratio
1.56
Revenue / Employee
343.28M
Employees
332
Market Cap
177.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.49B | -275.36B | -77.38% |
| Dec 31, 2023 | 355.85B | 161.95B | 83.53% |
| Dec 31, 2022 | 193.89B | 61.57B | 46.53% |
| Dec 31, 2021 | 132.33B | -125.64B | -48.70% |
| Dec 31, 2020 | 257.97B | 207.58B | 412.01% |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |